Most healthcare insights teams will enter 2027 with about the same budget they had in 2026 and a longer list of questions to answer. Gartner's 2025 CMO Spend Survey found marketing budgets flat at 7.7% of company revenue, and 59% of CMOs said they lack the budget to execute their strategy (Gartner). Research budgets usually sit inside or beside those commercial budgets, and they feel the same squeeze.
The cost of good evidence keeps climbing at the same time. Stakeholders want research faster and cheaper, a pressure GreenBook's GRIT research says can pull teams away from the fundamentals that make research credible (GreenBook). Healthcare professionals remain hard to reach: In a study of physician specialists, 35% completed a web survey, and 60% of nonrespondents who gave a reason cited survey burden or lack of time (BMC Medical Research Methodology).
A flat budget can still buy more insight. The teams that get the most from 2027 will tie every study to a business decision, pay for the respondents who can inform it and build data that keep working after the final readout.
Five Questions to Ask Before You Approve a Study
Run every proposed project through five questions. If a study can’t answer the first two clearly, it should wait.
- Business impact: Which decision will this study inform, and what does a wrong call cost?
- Audience: Who is best positioned to inform that decision, and what will it take to reach them?
- Methodology: Does the decision require a measurement, an explanation or both?
- Long-term value: Can the data help answer next year’s questions, too?
- Actionability: Who will act on the findings, and what will they do differently?
Together, these questions turn the annual budget exercise into a conversation about what the business needs to know and what that knowledge is worth.
1. Business Impact: Start with the Decisions on the Calendar
Most research budgets take shape around requests that already landed. A brand team wants concept feedback. Marketing wants to know how physicians perceive a competitor. Leadership wants a read on a new therapeutic area. Each request may be sound, but funding them one at a time produces a stack of studies that answer separate questions that build toward nothing larger.
So, how do you bridge those department silos to develop research plans that work for the business? Start with the decisions the organization expects to make in the next 12 months, instead. Will it launch into a new indication? Reposition a brand after a label change? Price against a new competitor? Refine segmentation ahead of a field force realignment? List those decisions, estimate what each is worth, and rank them. That ranked list becomes the filter for every research request.
A study tied to a launch or market-entry decision earns a larger share of the budget than one that produces interesting reading with no decision attached. Smaller questions still have a place, as long as each names the decision it serves and the person who will make it. If no one can name either, cut the study.
2. Audience: Budget for the Respondents Who Matter
In healthcare research, the sample often decides whether a study is worth its cost. Oncologists, rare disease specialists, payers, health system pharmacy directors and patients with low-prevalence conditions differ widely in how reachable they are and how much their views should weigh on a given decision.
These audiences keep getting harder to reach. In the specialist study cited above, response ranged from 27% in psychiatry to 47% in neurology and neurosurgery, and the authors note survey response rates in health research have declined for a decade (BMC Medical Research Methodology). A budget built on easy access will either overrun or quietly swap in an easier audience.
Plan for the real difficulty:
- Define the population first: specialty, practice setting, decision role, prescribing volume or patient experience.
- Separate must-have perspectives from nice-to-have ones so cuts don’t negate the overall efficacy of the program and projects.
- Price recruitment, incentives and field time by audience, using each group’s actual difficulty, instead of a blended average.
- Treat verification as its own line item. A fraudulent or misqualified respondent costs as much as a real one and does more damage.
Once you count the decisions they mislead, 200 completes from the wrong respondents cost more than 60 from the right ones.
3. Methodology: Match the Method to the Decision
Quantitative research measures. It sizes segments, compares groups and shows how common an attitude or behavior is across a defined population. Qualitative research explains. It surfaces motivations, maps experiences and shows why a physician hesitates to prescribe, or why a patient stops treatment. The decision determines which one the budget should buy.
If the brand team needs to know whether a message lifts intent among high prescribers, fund a quantitative design with enough sample to detect the difference. If a concept underperforms and no one can say why, fund in-depth interviews before paying for a larger survey that will only confirm the problem.
Many healthcare decisions call for both, in sequence: Explore with qualitative work, then size and validate with quantitative. The National Institutes of Health’s Office of Behavioral and Social Sciences Research publishes best practices for mixed methods research in the health sciences for exactly this approach. Phasing also protects the budget. The qualitative phase can sharpen the survey so it costs less, or it can show the survey isn’t needed at all.
Skip any methodology the team would buy only because it used it last year or because it sounds comprehensive.
4. Long-Term Value: Fund Data that Answers More than One Question
The most overlooked budget lever is data that stays useful after the readout. A study built to answer one question in one quarter often can’t be reused. Its segments don’t match the last study’s, its measures use different wording, and its results live in a slide deck no one can query.
A few design choices change that:
- Keep audience definitions and segmentation consistent across studies so results can be compared.
- Carry core measures forward, such as awareness, consideration and satisfaction, with the same wording and scales.
- Store respondent-level data in a structured, documented format the team can return to.
Scientists formalized this standard in the FAIR Guiding Principles, which calls for data that is findable, accessible, interoperable, and reusable. Commercial research teams can hold their own data to the same bar. A modest design investment this year sets a baseline for next year, cuts duplicate studies, and lets the team answer new questions without new fieldwork. On a flat budget, that reuse may be the least expensive insight available.
5. Actionability: Budget for What Happens After Fieldwork
Research budgets usually itemize recruitment, fieldwork and data collection, then treat analysis and reporting as an afterthought. Research creates value only when findings change a decision, so the work that carries findings to that decision belongs in the original budget.
Before approving a project, ask who will receive the findings, what they will decide with those findings, and in what format they to receive those insights to leverage them properly. A brand lead preparing for a launch review needs a clear recommendation, and 80 slides of crosstabs won’t deliver that.
Scale the investment to the decision. A tracking wave may need only a short dashboard update. A segmentation that will redraw sales territories needs deeper analysis, synthesis with sales and claims data, and a working session with the commercial team. By December 2027, the goal is a short list of decisions research changed, in place of a shelf of reports no one opened.
Build a Research Program that Compounds
Annual planning is a chance to decide what the organization’s research capability should look like three years from now, along with which studies to run in the next 12 months. When studies share definitions, measures, and data structures, each one makes the next faster, cheaper, and smarter.
That requires a partner who understands the business problem as well as the research. At TriVoca Health, the work starts before anyone writes the first question. We clarify the decision, define the audience that can inform it, choose the method that will produce the evidence and structure the data, so it supports the next decision too.
Sometimes that means challenging the original request. A critical decision may deserve more investment. A sprawling study may work better at half the scope. And the most valuable investment may be a framework that serves several decisions instead of another standalone project.
Planning your 2027 research budget? Talk with TriVoca about where your next research dollar will do the most work.
Sources
Gartner, “Gartner 2025 CMO Spend Survey Reveals Marketing Budgets Have Flatlined at Seven Percent of Overall Company Revenue,” May 12, 2025
GreenBook, GRIT Report
Cunningham, C.T., et al., “Exploring physician specialist response rates to web-based surveys,” BMC Medical Research Methodology, 2015
NIH Office of Behavioral and Social Sciences Research, Best Practices for Mixed Methods Research in the Health Sciences, 2011
Wilkinson, M.D., et al., “The FAIR Guiding Principles for scientific data management and stewardship,” Scientific Data, 2016